Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart

Hypertension

Volumn 55, Issue 2, 2010, Pages 270-276

  Levick, Scott P ^a   Murray, David B ^b   Janicki, Joseph S ^a   Brower, Gregory L ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Cytokines; Fibrosis; Inflammation; Mast cell; Substance P; Sympathectomy; Sympathetic nervous system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN II; COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPEPTIDE; NORADRENALIN; SUBSTANCE P;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART MUSCLE FIBROSIS; HYPERTENSION; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHECTOMY;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTENSION; INFLAMMATION MEDIATORS; MALE; MYOCYTES, CARDIAC; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUBSTANCE P; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR REMODELING;

EID: 74949095694     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.142042     Document Type: Article

References (33)

1. Pepper GS, Lee RW. Sympathetic activation in heart failure and its treatment with /3-blockade. Arch Intern Med. 1999;159:225-234.
2. Perlini S, Palladini G, Ferrero I, Tozzi R, Fallarini S, Facoetti A, Nano R, Clari F, Busca G, Fogari R, Ferrari AU. Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. Hypertension. 2005;46:1213-1218.
3. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med. 2002;195:375-381.
4. Panizo A, Mindan FJ, Galindo MF, Cenarruzabeitia E, Hernandez M, Diez J. Are mast cells involved in hypertensive heart disease? J Hypertens. 1995;13:1201-1208.
5. Shiota N, Rysa J, Kovanen PT, Ruskoaha H, Kokkonen JO, Lindstedt KA. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens. 2003;21:1935-1944.
6. Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE, Brower GL. Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension. 2009;53:1041-1047.
7. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension. 2004;43:739-745.
8. Kagitani S, Ueno H, Hirade S, Takahashi T, Takata M, Inoue H. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J Hypertens. 2004;22:1007-1015.
9. Yu Q, Watson RR, Marchalonis JJ, Larson DF. A role for T lymphocytes in mediating cardiac diastolic function. Am J Physiol Heart Circ Physiol. 2005;289:H643-H651.
10. Yu Q, Horak K, Larson DF. Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension. 2006;48: 98-104.
11. Arizono N, Matsuda S, Hattori T, Kojima Y, Maeda T, Galli SJ. Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin: similarities of distances between neural processes and mast cells, eosinophils, or plasma cells in the jejunal lamina propria. Lab Invest. 1990;62:626-634.
12. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R. Mast cells: a unique source of renin. Proc Natl Acad Sci USA. 2004;101:13607-13612.
13. Blennerhassett MG, Janiszewski J, Bienenstock J. Sympathetic nerve contact alters membrane resistance of colls of the RBL-2H3 mucosal mast cell line. Am J Respir Cell Mol Biol. 1992;6:504-509.
14. Madden KS, Sanders VM, Felten DL. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol. 1995;35:417-448.
15. Morgan LG, Levick SP, Voloshenyuk TG, Murray DB, Forman MF, Brower GL, Janicki JS. A novel technique for isolating functional mast cells from the heart. Inflamm Res. 2008;57:1-6.
16. Provoost AP, De Jong W. Differential development of renal, DOCA-salt, and spontaneous hypertension in the rat after neonatal sympathectomy. Clin Exp Hypertens. 1978;1:177-189.
17. Bensley SH. Pinacyanol erthrosinate as a stain for mast cells. Stain Technol. 1952;27:269-273.
18. Tomita H, Egashira K, Kubo-Inoue M, Usui M, Koyanagi M, Shimokawa H, Takeya M, Yoshimura T, Takeshita A. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Thromb Vasc Biol. 1998;18:1456-1464.
19. Kawashima T. The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl). 2005;209:425-438.
20. Facoetti A, Fallarini S, Miserere S, Bertolotti A, Ferrero I, Tozzi R, Gatti C, Palladini G, Perlini S, Nano R. Histochemical study of cardiac mast cells degranulation and collagen deposition: interaction with the cathe-colaminergic system in the rat. Eur J Histochem. 2006;50:133-140.
21. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience. 1992;48:501-524.
22. Kessler JA, Adler JE, Bell WO, Black IB. Substance P and somatostatin metabolism in sympathetic and special sensory ganglia in vitro. Neuroscience. 1983;9:309-318.
23. Furness JB, Costa M, Papka RE, Della NG, Murphy R. Neuropeptides contained in peripheral cardiovascular nerves. Clin Exp Hypertens A. 1984;6:91-106.
24. Suzuki R, Furuno T, Teshima R, Nakanishi M. Bi-directional relationship of in vitro mast cell-nerve communication observed by confocal laser scanning microscopy. Biol Pharm Bull. 2001;24:291-294.
25. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, Bunnett NW. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med. 2000;6:151-158.
26. Mackins CJ, Kano S, Seyedi N, Schafer U, Reid AC, Machida T, Silver RB, Levi R. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/ reperfusion. J Clin Invest. 2006;116:1063-1070.
27. Reid AC, Silver RB, Levi R. Renin: at the heart of the mast cell. Immunol Rev. 2007;217:123-140.
28. Henegar JR, Brower GL, Kabour A, Janicki JS. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am J Physiol Heart Circ Physiol. 1995;269:H1564-H1569.
29. Henegar JR, Schwartz DD, Janicki JS. ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation. Am J Physiol Heart Circ Physiol. 1998;275:H534-H541.
30. Coderre TJ, Basbaum AI, Levine JD. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J Neurophysiol. 1989;62:48-58.
31. Rogge L. A genomic view of helper T cell subsets. Ann N Y Acad Sci. 2002;975:57-67.
32. Perlini S, Ferrero I, Palladini G, Tozzi R, Gatti C, Vezzoli M, Cesana F, Janetti MB, Clari F, Busca G, Mancia G, Ferrari AU. Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure. Hypertension. 2006;48:93-97.
33. Kinet JP. The essential role of mast cells in orchestrating inflammation. Immunol Rev. 2007;217:5-7.